Cetera Investment Advisers’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$525K Sell
5,528
-3,074
-36% -$377K ﹤0.01% 3466
2025
Q4
$1.42M Buy
8,602
+5,700
+196% +$756K ﹤0.01% 2527
2025
Q3
$300K Buy
+2,902
New +$285K ﹤0.01% 3834
2024
Q2
Sell
-67
Closed -$966 3821
2024
Q1
$966 Hold
67
﹤0.01% 3677
2023
Q4
$1.8K Hold
67
﹤0.01% 2220
2023
Q3
$2.02K Hold
67
﹤0.01% 2185
2023
Q2
$4.22K Hold
67
﹤0.01% 2171
2023
Q1
$10.1K Hold
67
﹤0.01% 2137
2022
Q4
$19K Buy
+67
New +$12.9K ﹤0.01% 2064
2022
Q3
Sell
-67
Closed -$32K 1834
2022
Q2
$32K Buy
+67
New +$79K ﹤0.01% 1788

Other funds holding NUTX

Cetera Investment Advisers's NUTX Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Nutex Health (NUTX) stake by 36% in Q1 2026, selling an estimated $377K and leaving 5,528 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

Cetera Investment Advisers first reported a position in NUTX in Q2 2022 and has held it in 10 quarters since. The position peaked at $1.42M in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Cetera Investment Advisers held 5,528 shares of Nutex Health worth $525K as of Q1 2026.
  • Cetera Investment Advisers sold 3,074 Nutex Health shares in Q1 2026, an estimated $377K.
  • Nutex Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3466 holding.
  • Cetera Investment Advisers first reported a position in Nutex Health in Q2 2022 and has held it in 10 quarters since.
  • Cetera Investment Advisers's Nutex Health position peaked at $1.42M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.